started · updated
South Africa to license FMD vaccine production to private sector
The Agricultural Research Council (ARC) has approved a proposal to allow qualifying private companies to manufacture its locally developed Foot-and-Mouth Disease (FMD) vaccine through intellectual property licensing agreements. Agriculture Minister Willie Aucamp announced the move to Parliament, stating it aims to address production constraints and safeguard South Africa’s livestock sector during a significant FMD epidemic.
South Africa requires approximately 25 million vaccine doses annually to protect its cattle population. While the ARC has developed an effective vaccine that requires only one annual administration, it currently lacks the manufacturing capacity to meet national demand. To date, 21 million doses have been produced or imported, primarily from companies in Turkey and Argentina, as well as the Botswana Vaccine Institute.
Under the new arrangement, the ARC will continue to expand its own production capacity while utilizing third-party manufacturers to provide additional scale. Income generated from these licensing agreements will be ringfenced for the ARC.
Entities
Agricultural Research Council · South Africa · Willie Aucamp